Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of l-prolyl-l-leucyl-glycinamide

This publication has 20 references indexed in Scilit:

• Prolyl-leucyl-glycinamide, thyrotropin-releasing hormone and β-endorphin-(10–16), like antidepressants, antagonize melatonin-induced behavioural changes in rats
  European Journal of Pharmacology, 1995
• Improvement in major depression after low subcutaneous doses of MIF-1
  Journal of Affective Disorders, 1994
• Biphasic effects of MIF-1 and Tyr-MIF-1 on apomorphine-induced stereotypy in rats
  Pharmacology Biochemistry and Behavior, 1986
• Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats
  Neuropharmacology, 1984
• The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites
  General Pharmacology: The Vascular System, 1982
• Neuroleptic Drug-Induced Dopamine Receptor Supersensitivity: Antagonism by L-Prolyl-L-Leucyl-Glycinamide
  Science, 1981
• Effect of L-prolyl-L-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindings
  Peptides, 1981
• Dose-related biphasic effect of prolyl-leucyl-glycinamide (MIF-I) in depression
  American Journal of Psychiatry, 1978
• POTENTIATION OF LEVODOPA EFFECT BY INTRAVENOUS L-PROLYL-L-LEUCYL-GLYCINE AMIDE IN MAN
  The Lancet, 1975
• Regulation of Formation and Proposed Structure of the Factor Inhibiting the Release of Melanocyte-Stimulating Hormone
  Proceedings of the National Academy of Sciences, 1971